IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent

Journal of Immunology

Volumn 166, Issue 5, 2001, Pages 3542-3548

  Tekkanat, K K ^a   Maassab, H F ^a   Cho, D S ^a   Lai, J J ^a   John, A ^a   Berlin, A ^a   Kaplan, M H ^a   Lukacs, N W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 13 ANTIBODY; INTERLEUKIN 4 ANTIBODY; NEUTRALIZING ANTIBODY; STAT6 PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL DAMAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EPITHELIUM CELL; IMMUNE RESPONSE; LUNG FUNCTION; MOUSE; MUCUS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION;

EID: 0035284898     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.5.3542     Document Type: Article

References (56)

1. Hospitalization patterns in severe acute asthma in children
2. Severity of childhood asthma by socioeconomic status
3. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo
4. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen
5. Definition of pediatric asthma and associated risk factors
6. The incidence of respiratory tract infection in adults requiring hospitalization for asthma
7. Mechanisms of virus induced exacerbations of asthma
8. Childhood asthma following hospitalization with acute viral bronchiolitis in infancy
9. The relationship between proved viral bronchiolitis and subsequent wheezing
10. Increased production of IFN-γ and cysteinyl leukotrienes in virus-induced wheezing
11. The role of respiratory viruses in asthma
12. T cells as orchestrators of the asthmatic response
13. + T cells in asthma
14. Characterization of the T cell response to human rhinovirus in children: Implications for understanding the immunopathology of the common cold
15. Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins
16. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection
17. Requirement for IL-13 independently of IL-4 in experimental asthma
18. Interleukin-13: Central mediator of allergic asthma
19. Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness
20. Intranasal IFN-γ gene transfer protects BALB/c mice against respiratory syncytial virus infection
21. -/- mice: The role of mast cells
22. Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis
23. Specific ELISAs for the detection of human macrophage inflammatory protein-1α and β
24. Primary respiratory syncytial virus infection in mice
25. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response
26. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells
27. The IL-4 receptor α-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression
28. Respiratory syncytial virus infection
29. Immunology of respiratory viral infections
30. Host responses to respiratory virus infection and immunization
31. Airway wall liquid: Sources and role as an amplifier of bronchoconstriction
32. The pathology of asthma
33. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
34. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism
35. T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice
36. The effect of IL-12 treatment on vaccine-enhanced illness during infection with respiratory syncytial virus
37. Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity
38. Persistence of airway hyperresponsiveness and viral antigen following respiratory syncytial virus bronchiolitis in young guinea-pigs
39. Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis
40. Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs
41. Decreased interleukin-12 levels in umbilical cord blood in children who developed acute bronchiolitis
42. IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness
43. Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes
44. Interferon-γ expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity
45. Intranasal IFN-γ gene transfer protects BALB/c mice against respiratory syncytial virus infection
46. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls
47. Acute and long-term effects of viral bronchiolitis in infancy
48. Effects of IL-12 on the response and susceptibility to experimental viral infections
49. + T lymphocytes, and NK cells
50. Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium
51. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice
52. Primary respiratory syncytial virus infection in mice
53. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production
54. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice
55. Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis
56. Respiratory syncytial virus G-protein modulates cytokine release from human peripheral blood mononuclear cells